CURRENT ASPECTS OF USE OF NASAL VASOCONSTRICTORS AND ADJUNCTIVE AGENTS IN PEDIATRIC PRACTICE
https://doi.org/10.21518/2079-701X-2018-2-114-117
Abstract
Nasal forms of vasoconstrictor agents (decongestants) are one of the most frequently prescribed groups of drugs in the therapy of inflammatory diseases of the nasal cavity. The article provides an overview of the mechanisms of action of decongestants, safety and the evidence base for the efficacy of decongestants in various upper respiratory tract diseases. It is concluded that when choosing a nasal agent, the preference should be given to decongestants with a higher level of safety – modern imidazolines (primarily xylometazoline) over the “first generation” decongestants (naphazoline).
About the Authors
D. A. Tulupov
Russian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
PhD in medicine.
MoscowF. A. Fedotov
Russian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
Moscow
E. P. Karpova
Russian Medical Academy of Continuing Postgraduate Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD, Prof.
MoscowV. A. Grabovskaya
Filatov Children’s City Clinical Hospital No.13 of the Moscow Department of Health
Russian Federation
Russian Federation
References
1. Лопатин А.С. Сосудосуживающие препараты: механизм действия, клиническое применение и побочные эффекты. Российская ринология, 2007, 1: 43-49.
2. Corboz MR, Varty LM, Rizzo CA, Mutter JC, Rivelli MA, Wan Y, Umland S, Qiu H, Jakway J, McCormick KD, Berlin M, Hey JA. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa. Auton Autacoid Pharmacol, 2003, 23(4): 208-219.
3. Lacroix JS. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol. Scand, 1989, 136(suppl.581): 1-63.
4. Заплатников А.Л. Топические деконгестанты в педиатрической практике: безопасность и клиническая эффективность. Педиатрия, 2006, 6: 69–75.
5. Тулупов Д.А., Карпова Е.П. О безопасности применения назальных сосудосуживающих препаратов в педиатрической практике. Российская ринология, 2014, 1: 12-14.
6. Hofmann T, Koidl B, Wolf G. In vitro studies of the effect of vasoconstrictor nose drops on ciliary epithelium of human nasal mucosa. Laryngorhinootologie, 1995, 74(9): 564-567.
7. Boek WM, Graamans K, Natzijl H, van Rijk PP, Huizing EH. Nasal mucociliary transport: new evidence for key role of ciliary beat frequency. Laryngoscope, 2002, 112(3): 570-573.
8. Deitmer T, Scheffler R. The effect of different preparations of nasal decongestant on ciliary beat frequency in vitro. Rhinology, 1993, 31(4): 151-153.
9. Васина Л.А. Влияние местных деконгестантов, содержащих раствор ксилометазолина, на цилиарную активность реснитчатых клеток. Российская ринология, 2008, 3: 14-17.
10. Карпова Е.П., Тулупов Д.А. Сосудосуживающие препараты в педиатрической практике. Эффек тивная фармакотерапия. Педиатрия, 2012, 1: 18-24.
11. Verse T, Klöcker N, Riedel F, Pirsig W, Scheithauer MO. Dexpanthenol nasal spray in comparison to dexpanthenol nasal ointment. A prospective, randomised, open, cross-over study to compare nasal mucociliary clearance. HNO, 2004, 52(7): 611-615.
12. Jagade MV, Langade DG, Pophale RR, Prabhu A. Oxymetazoline plus dexpanthenol in nasal congestion. Indian J Otolaryngol Head Neck Surg, 2008, 60(4): 393-397.
13. Карпова Е.П., Вагина Е.Е. Ирригационная терапия в лечении и профилактике инфекций в детской оториноларингологии. Эффективная фармакотерапия, 2011, 29: 40-45.
14. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol, 2006, 16(3): 148-155.
15. Shefrin AE, Goldman RD. Use of over-the-counter cough and cold medications in children. Canadian Family Physician, 2009, 55(11): 1081-1083.
16. Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Cough and Cold Medication Use by US Children, 1999–2006: Results From the Slone Survey. Pediatrics, 2008, 122(2): e323-e329.
17. Mahieu LM, Rooman RP, Goossens E. Imidazoline intoxication in children. Eur J Pediatr, 1993, 152(11): 944-946.
18. Wenzel S, Sagowski C, Laux G. Course and therapy of intoxication with imidazoline derivate naphazoline. Int J Pediatr Otorhinolaryngol, 2004, 68(7): 979-83.
19. Taverner D, Latte GJ. WITHDRAWN: Nasal decongestants for the common cold. Cochrane Database Syst Rev, 2009, Apr 15, 2: CD001953.
20. Shaikh N, Wald ER, Pi M. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Database Syst Rev, 2010 Dec 8, 12: CD007909.
21. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ, Global Allergy and Asthma European Network, Grading of Recommen dations Assessment, Develop ment and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol, 2010, 126(3): 466-476.
22. Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ. European position paper on rhinosinusitis and nasal polyps 2012 (EP3OS). Rhinology, 2012, 50(23): 1-299.
23. Roberts G, Xatzipsalti M, Borrego LM, Custovic A, Halken S, Hellings PW, Papadopoulos NG, Rotiroti G, Scadding G, Timmermans F, Valovirta E. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy, 2013, 68(9): 1102-1116. doi: 10.1111/all.12235.
24. http://нмаору.рф/documents.html.
25. http://www.pediatr-russia.ru/sites/default/files/_kr_ar.pdf.
26. Тулупов Д.А., Карпова Е.П. Гипертрофия аденоидных вегетаций и аденоиды у детей. Пособие для врачей. М.: Петроруш, 2012.
Review
For citations:
Tulupov DA, Fedotov FA, Karpova EP, Grabovskaya VA. CURRENT ASPECTS OF USE OF NASAL VASOCONSTRICTORS AND ADJUNCTIVE AGENTS IN PEDIATRIC PRACTICE. Meditsinskiy sovet = Medical Council. 2018;(2):114-117. (In Russ.) https://doi.org/10.21518/2079-701X-2018-2-114-117
Views:
1057
Email this article 